What Is Quality by Design and Why It Matters in PharmaUntitledA Science-Led Route to Consistent Quality
Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical and biopharmaceutical development that builds quality into a product from the design stage rather than testing it in at the end. This Quality by Design training in Serbia equips formulation, analytical, quality and regulatory professionals to apply the QbD method with confidence on real development projects. Grounded in the ICH Q8(R2), Q9, Q10 and Q11 guidelines, the course walks you through the full QbD workflow: defining the Quality Target Product Profile (QTPP), identifying Critical Quality Attributes (CQAs), running risk assessment, using Design of Experiments (DoE) to map the design space, and building a robust control strategy. These are the same tools that the FDA, EMA and Serbia's ALIMS increasingly expect to see in modern development and manufacturing submissions. Delivered in live online and classroom formats, the one-day programme suits professionals across the country's growing pharma sector, from established manufacturers to contract producers supplying the EU. You learn a practical skill you can apply the next working day, and take product development from trial and error to controlled, predictable quality.










